Paper32655804
Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
Zheng J and 14 others. Am J Transl Res, 2020. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation. Papers, record 32655804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32655804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30013444 | The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma. | Int J Med Sci | 2018 | https://conductscience.org/library/papers/30013444 | PubMed |
| 2 | 11905674 | SIOPEL trials using preoperative chemotherapy in hepatoblastoma. | Lancet Oncol | 2000 | https://conductscience.org/library/papers/11905674 | PubMed |
| 3 | 12939582 | Epidemiology of primary hepatic malignancies in U.S. children. | Hepatology | 2003 | https://conductscience.org/library/papers/12939582 | PubMed |
| 4 | 19751877 | Hep G2 is a hepatoblastoma-derived cell line. | Hum Pathol | 2009 | https://conductscience.org/library/papers/19751877 | PubMed |
| 5 | 12586629 | Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. | Blood | 2003 | https://conductscience.org/library/papers/12586629 | PubMed |
| 6 | 21859152 | Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. | J Proteome Res | 2011 | https://conductscience.org/library/papers/21859152 | PubMed |
| 7 | 28923827 | Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma. | EMBO Mol Med | 2017 | https://conductscience.org/library/papers/28923827 | PubMed |
| 8 | 21768450 | Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21768450 | PubMed |
| 9 | 14746860 | Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. | Eur J Cancer | 2004 | https://conductscience.org/library/papers/14746860 | PubMed |
| 10 | 23831416 | Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. | Lancet Oncol | 2013 | https://conductscience.org/library/papers/23831416 | PubMed |
| 11 | 25078725 | Mutational landscape of hepatoblastoma goes beyond the Wnt-β-catenin pathway. | Hepatology | 2014 | https://conductscience.org/library/papers/25078725 | PubMed |
| 12 | 29687726 | The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma. | Antioxid Redox Signal | 2019 | https://conductscience.org/library/papers/29687726 | PubMed |
| 13 | 4290059 | Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. | Cancer | 1967 | https://conductscience.org/library/papers/4290059 | PubMed |
| 14 | 28535186 | FXR-Gankyrin axis is involved in development of pediatric liver cancer. | Carcinogenesis | 2017 | https://conductscience.org/library/papers/28535186 | PubMed |
| 15 | 25656995 | Physiological and pathological views of peroxiredoxin 4. | Free Radic Biol Med | 2015 | https://conductscience.org/library/papers/25656995 | PubMed |
| 16 | 28174264 | Hippo signaling promotes JNK-dependent cell migration. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28174264 | PubMed |
| 17 | 22692949 | The epidemiology of hepatoblastoma. | Pediatr Blood Cancer | 2012 | https://conductscience.org/library/papers/22692949 | PubMed |
| 18 | 7542025 | Liver tumors in neonates and very young infants: diagnostic pitfalls and therapeutic problems. | Eur J Pediatr Surg | 1995 | https://conductscience.org/library/papers/7542025 | PubMed |
| 19 | 22916164 | Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth. | PLoS One | 2012 | https://conductscience.org/library/papers/22916164 | PubMed |
| 20 | 29237274 | Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer. | Antioxid Redox Signal | 2018 | https://conductscience.org/library/papers/29237274 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39773476 | The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma. | Diagn Pathol | 2025 | https://conductscience.org/library/papers/39773476 | PubMed |
| 37787446 | The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role. | Histol Histopathol | 2023 | https://conductscience.org/library/papers/37787446 | PubMed |
| 34477212 | The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis. | Histol Histopathol | 2021 | https://conductscience.org/library/papers/34477212 | PubMed |
| 33456675 | Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33456675 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PRDX4 | 10549 | PubTator's text mining | https://conductscience.org/library/genes/10549 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32655804
GET https://conductscience.org/api/papers/v1/32655804/references?page=2